Pharmacologic venous thromboembolism prophylaxis is not associated with post sphincterotomy bleeding after endoscopic retrograde cholangiopancreatography

Acosta, 2016, The management of antithrombotic agents for patients undergoing GI endoscopy, Gastrointest Endosc, 83, 3, 10.1016/j.gie.2015.09.035 Krill, 2019, Endoscopic biliary sphincterotomy on thienopyridine therapy compared to low dose aspirin alone has similar outcomes, Minerva Gastroenterol Dietol, 65, 248, 10.23736/S1121-421X.19.02598-4 Abdel Samie, 2013, Biliary-pancreatic endoscopic and surgical procedures in patients under dual antiplatelet therapy: a single-center study, Clin Endosc, 46, 395, 10.5946/ce.2013.46.4.395 Mok, 2017, Safety and efficacy of minimal biliary sphincterotomy with papillary balloon dilation (m-EBS+EPBD) in patients using clopidogrel or anticoagulation, Endosc Int Open, 5, E157, 10.1055/s-0042-120225 Joyce, 2005, Update on biliary endoscopy, Curr Opin Gastroenterol, 21, 354, 10.1097/01.mog.0000158113.67087.8b Leung, 1995, Endoscopic sphincterotomy-induced hemorrhage: a study of risk factors and the role of epinephrine injection, Gastrointest Endosc, 42, 550, 10.1016/S0016-5107(95)70009-9 Freeman, 1996, Complications of endoscopic biliary sphincterotomy, N Engl J Med, 335, 909, 10.1056/NEJM199609263351301 Cotton, 2009, Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years, Gastrointest Endosc, 70, 80, 10.1016/j.gie.2008.10.039 Gholson, 1996, Delayed hemorrhage following endoscopic retrograde sphincterotomy for choledocholithiasis, Dig Dis Sci, 41, 831, 10.1007/BF02091518 Nelson, 1994, Major hemorrhage from endoscopic sphincterotomy: risk factor analysis, J Clin Gastroenterol, 19, 283, 10.1097/00004836-199412000-00004 Vásconez, 1998, Injection treatment of hemorrhage induced by endoscopic sphincterotomy, Endoscopy, 30, 37, 10.1055/s-2007-993726 Boujaoudé, 1994, Management of clinically relevant bleeding following endoscopic sphincterotomy, Endoscopy, 26, 217, 10.1055/s-2007-1008946 Onal, 2013, Do aspirin and non-steroidal anti-inflammatory drugs increase the risk of post-sphincterotomy hemorrhage–a case-control study, Clin Res Hepatol Gastroenterol, 37, 171, 10.1016/j.clinre.2012.04.010 Ferreira, 2007, Clinically significant delayed postsphincterotomy bleeding: a twelve year single center experience, Minerva Gastroenterol Dietol, 53, 215 Kim, 1999, Endoscopic hemostasis in sphincterotomy-induced hemorrhage: its efficacy and safety, Endoscopy, 31, 431, 10.1055/s-1999-42 Dobesh, 2009, Economic burden of venous thromboembolism in hospitalized patients, Pharmacotherapy, 29, 943, 10.1592/phco.29.8.943 Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 Tagalakis, 2013, Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort, Am J Med, 126, 10.1016/j.amjmed.2013.02.024 Silverstein, 1998, Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, 158, 585, 10.1001/archinte.158.6.585 White, 2003, The epidemiology of venous thromboembolism, Circulation, 107, I4 Heit, 2001, Incidence of venous thromboembolism in hospitalized patients vs community residents, Mayo Clin Proc, 76, 1102, 10.4065/76.11.1102 Geerts, 2004, Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S Flanders, 2014, Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study, JAMA Intern Med, 174, 1577, 10.1001/jamainternmed.2014.3384 Schünemann, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients, Blood Adv, 11, 3198, 10.1182/bloodadvances.2018022954 Turpie, 2002, Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies, Arch Intern Med, 162, 1833, 10.1001/archinte.162.16.1833 Strebel, 2002, Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?, Arch Intern Med, 162, 1451, 10.1001/archinte.162.13.1451 McLynn, 2018, Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery, Spine J, 06, 970, 10.1016/j.spinee.2017.10.013 Leonardi, 2006, The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials, Arch Surg, 141, 797, 10.1001/archsurg.141.8.790 Ohta, 2019, The impact of pharmacological thromboprophylaxis and disease-stage on postoperative bleeding following colorectal cancer surgery, World J Surg Oncol, 17, 110, 10.1186/s12957-019-1653-1 Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines, Chest, 141, e278S, 10.1378/chest.11-2404 Cotton, 2010, A lexicon for endoscopic adverse events: report of an ASGE workshop, Gastrointest Endosc, 71, 446, 10.1016/j.gie.2009.10.027 Chandrasekhara, 2017, Adverse events associated with ERCP, Gastrointest Endosc, 85, 32, 10.1016/j.gie.2016.06.051 Barbar, 2010, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J Thromb Haemost, 8, 2450, 10.1111/j.1538-7836.2010.04044.x Nendaz, 2014, Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit assessment of thromboembolic risk and prophylaxis for medical patients in SwitzErland (ESTIMATE), Thromb Haemost, 111, 531, 10.1160/TH13-05-0427 Spyropoulos, 2011, Predictive and associative models to identify hospitalized medical patients at risk for VTE, Chest, 140, 706, 10.1378/chest.10-1944 Kucher, 2005, Gender differences in the administration of prophylaxis to prevent deep venous thrombosis, Thromb Haemost, 93, 284, 10.1160/TH04-08-0513 Chang, 2007, Gender bias in cardiovascular testing persists after adjustment for presenting characteristics and cardiac risk, Acad Emerg Med, 14, 599, 10.1197/j.aem.2007.03.1355